Current and emerging opportunities for molecular simulations in structure-based drug design

Area of Science:

• Computational chemistry
• Biophysics
• Drug discovery

Background:

• Molecular simulations offer insights into biomolecular complexes.
• Advancements in hardware and energetics enhance understanding of molecular recognition.
• Current limitations exist in applying simulations to drug design.

Purpose of the Study:

• To provide an overview of molecular simulation capabilities and limitations in computer-aided drug design.
• To highlight the growing role of molecular simulations in interpreting biophysical data.
• To discuss the potential of simulations in guiding ligand design strategies.

Main Methods:

• Review of current molecular simulation techniques.
• Analysis of computational hardware and energetics improvements.
• Examination of ligand design strategies derived from simulation data.

Main Results:

• Molecular simulations are increasingly guiding the interpretation of biophysical measurements.
• Detailed analysis of computed structural ensembles yields ligand design strategies.
• Improvements in computational power and energy representations enhance understanding of molecular recognition.

Conclusions:

• Molecular simulations show significant promise for computer-aided drug design.
• Routine application to ligand optimization requires extensive validation and automated protocols.
• Simulations are poised to become more integral to drug discovery workflows.